Saturday July 11, 2020

Pharma firms scour archives in hunt for effective treatments

Repurposing existing drugs or trying out novel therapies could prove effective in treating Covid-19, but there are many ‘ifs’ and ‘maybes’ to be negotiated

22nd March, 2020
3
Paramedics carry a coronavirus patient on a stretcher to hospital in Naples Pictures: Getty Images

The coronavirus will not wait for the historically glacial pace of drug development. A vaccine, we have been repeatedly warned, is at least 12 to 18 months away. The more immediate focus is on identifying drugs already licensed and effective in treating those who suffer the most severe effects of Covid-19.

This is why pharma companies are rummaging through their archives to see if anything fits the bill when it comes to treating the very specific complications...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The Private Hospital Association is claiming that some of its members have been hugely underpaid by the state

Aiden Corkery | 6 days ago

The extent of the psychological fallout from the coronavirus pandemic has yet to fully show itself, but some experts warn that forecasts of a tsunami of new referrals are premature

Susan Mitchell | 6 days ago

Pitting one against the other makes no sense, because they are tied together on the same side of the scales

Tomás Ryan | 6 days ago